Bridgewater Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250,947
| Closed | -$31.2M | – | 659 |
|
|
2025
Q1 | $31.2M | Buy |
250,947
+58,912
| +31% | +$7.31M | 0.14% | 128 |
|
|
2024
Q4 | $23.6M | Buy |
192,035
+79,036
| +70% | +$9.73M | 0.11% | 143 |
|
|
2024
Q3 | $12.6M | Buy |
112,999
+11,864
| +12% | +$1.32M | 0.07% | 229 |
|
|
2024
Q2 | $10.8M | Sell |
101,135
-8,656
| -8% | -$924K | 0.06% | 242 |
|
|
2024
Q1 | $13.2M | Buy |
109,791
+19,375
| +21% | +$2.33M | 0.07% | 215 |
|
|
2023
Q4 | $11.1M | Buy |
90,416
+2,640
| +3% | +$325K | 0.06% | 230 |
|
|
2023
Q3 | $11.4M | Buy |
87,776
+76,599
| +685% | +$9.91M | 0.07% | 220 |
|
|
2023
Q2 | $1.39M | Buy |
+11,177
| New | +$1.39M | 0.01% | 529 |
|
|
2023
Q1 | – | Sell |
-3,373
| Closed | -$537K | – | 805 |
|
|
2022
Q4 | $537K | Sell |
3,373
-24,850
| -88% | -$3.96M | ﹤0.01% | 714 |
|
|
2022
Q3 | $3.76M | Buy |
+28,223
| New | +$3.76M | 0.02% | 441 |
|
|
2021
Q4 | – | Sell |
-2,200
| Closed | -$286K | – | 774 |
|
|
2021
Q3 | $286K | Buy |
+2,200
| New | +$286K | ﹤0.01% | 639 |
|
|
2021
Q1 | – | Sell |
-2,255
| Closed | -$372K | – | 534 |
|
|
2020
Q4 | $372K | Buy |
+2,255
| New | +$372K | ﹤0.01% | 485 |
|